Premium
Distribution of pathogen inhibition in the Lactobacillus isolates of a commercial probiotic consortium
Author(s) -
Chateau N.,
Castellanos I.,
Deschamps A.M.
Publication year - 1993
Publication title -
journal of applied bacteriology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.889
H-Index - 156
eISSN - 1365-2672
pISSN - 0021-8847
DOI - 10.1111/j.1365-2672.1993.tb02993.x
Subject(s) - listeria monocytogenes , probiotic , bacteriocin , microbiology and biotechnology , serotype , salmonella , lactobacillus , biology , escherichia coli , pathogenic bacteria , pathogen , bacteria , salmonella enteritidis , food science , antimicrobial , biochemistry , gene , genetics
Pure strains of Lactobacillus ssp. isolated from a commercial probiotic consortium were checked in a double layer solid medium for their inhibition activities against selected pathogenic bacteria including serotypes of Listeria monocytogenes, Escherichia coli and Salmonella. The antagonistic properties of the Lactobacillus strains may be related to the production of bacteriocin‐like compounds. All the pathogens tested were inhibited by one or a few strains of Lactobacillus, the best inhibition was observed against L. monocytogenes but the inhibition was also satisfactory against E. coli, Salm. typhimurium and Salm. enteritidis.